Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy

被引:14
作者
Rose, Jessica [1 ]
Wertheim, Betsy C. [2 ]
Guerrero, Marlon A. [1 ]
机构
[1] Univ Arizona, Sch Med, Dept Surg, Tucson, AZ 85724 USA
[2] Univ Arizona, Ctr Canc, Tucson, AZ 85724 USA
关键词
Thyroid cancer; Pediatric malignancies; Radiation treatment; CHILDHOOD-CANCER; THERAPEUTIC RADIATION; EXTERNAL RADIATION; SURVIVOR; ABNORMALITIES; NEOPLASMS; EXPOSURE; TUMORS;
D O I
10.1016/j.amjsurg.2012.07.030
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The aim of this study was to estimate the risk of thyroid cancer as a secondary malignancy after radiation treatment of primary pediatric malignancies. METHODS: Using the Surveillance, Epidemiology, and End Results database, we identified 7,670 patients from 1973 to 1988 with primary pediatric malignancies. The relative risk of thyroid cancer in irradiated patients was calculated using the Poisson regression model, and the Cox proportional hazards regression model was used for survival rates. RESULTS: The relative risk (RR) of thyroid cancer for children who received radiation was 2.22 (95% confidence interval [CI], 1.15-4.29). It was highest for central nervous system cancer (RR = 4.47) and lowest for those with leukemia (RR = 1.75). Mortality was significantly reduced for patients who received radiation as children; the hazard ratio was .80 (95% CI, .75-.86). CONCLUSIONS: Radiation for pediatric malignancies increases the risk of developing thyroid cancer as a secondary malignancy; however, these patients had localized disease and lower 20-year mortality. Published by Elsevier Inc.
引用
收藏
页码:881 / 886
页数:6
相关论文
共 20 条
[1]   Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence [J].
Acharya, S ;
Sarafoglou, K ;
LaQuaglia, M ;
Lindsley, S ;
Gerald, W ;
Wollner, N ;
Tan, C ;
Sklar, C .
CANCER, 2003, 97 (10) :2397-2403
[2]   The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer [J].
Brown, Aaron. P. ;
Chen, Jergin ;
Hitchcock, Ying J. ;
Szabo, Aniko ;
Shrieve, Dennis C. ;
Tward, Jonathan. D. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (02) :504-515
[3]   Thyroid carcinomas after irradiation for a first cancer during childhood [J].
de Vathaire, F ;
Hardiman, C ;
Shamsaldin, A ;
Campbell, S ;
Grimaud, E ;
Hawkins, M ;
Raquin, M ;
Oberlin, O ;
Diallo, I ;
Zucker, JM ;
Panis, X ;
Lagrange, JL ;
Daly-Schveitzer, N ;
Lemerle, J ;
Chavaudra, J ;
Schlumberger, M ;
Bonaïti, C .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (22) :2713-2719
[4]   Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature [J].
Gow, KW ;
Lensing, S ;
Hill, DA ;
Krasin, MJ ;
McCarville, MB ;
Rai, SN ;
Zacher, M ;
Spunt, SL ;
Strickland, DK ;
Hudson, MM .
JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (11) :1574-1580
[5]   THYROID ABNORMALITIES AFTER THERAPEUTIC EXTERNAL RADIATION [J].
HANCOCK, SL ;
MCDOUGALL, IR ;
CONSTINE, LS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1165-1170
[6]   Thyroid cancer after radiotherapy for childhood cancer [J].
Inskip, PD .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (05) :568-573
[8]   Cancer surveillance series: Recent trends in childhood cancer incidence and mortality in the United States [J].
Linet, MS ;
Ries, LAG ;
Smith, MA ;
Tarone, RE ;
Devesa, SS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (12) :1051-1058
[9]   Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors [J].
Miralbell, R ;
Lomax, A ;
Cella, L ;
Schneider, U .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03) :824-829
[10]   Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study [J].
Neglia, JP ;
Friedman, DL ;
Yasui, Y ;
Mertens, AC ;
Hammond, S ;
Stovall, M ;
Donaldson, SS ;
Meadows, AT ;
Robison, LL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (08) :618-629